Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell CarcinomaAly‐Khan A. Lalani, Toni K. Choueiri, Dominick Bossé et al.|European Urology Oncology|2019Cited by 96
A phase I study evaluating the combination of OSI-906, a dual inhibitor of insulin growth factor-1 receptor (IGF-1R) and insulin receptor (IR) with weekly paclitaxel (PAC) in patients with advanced solid tumors.Wael A. Harb, Srinivasu Poondru, C. Sessa et al.|Journal of Clinical Oncology|2011Cited by 7